An international research collaborative has determined that a promising anti-malarial compound tricks the immune system to rapidly destroy red blood cells infected with the malaria parasite but leave healthy cells unharmed.
St. Jude Children’s Research Hospital scientists led the study, which appears in the current online early edition of the Proceedings of the National Academy of Sciences (PNAS).
The compound, (+)-SJ733, was developed from a molecule identified in a previous St. Jude-led study that helped to jumpstart worldwide anti-malarial drug development efforts. Malaria is caused by a parasite spread through the bite of an infected mosquito. The disease remains a major health threat to more than half the world’s population, particularly children. The World Health Organization estimates that in Africa a child dies of malaria every minute.
In this study, researchers determined that (+)-SJ733 uses a novel mechanism to kill the parasite by recruiting the immune system to eliminate malaria-infected red blood cells. In a mouse model of malaria, a single dose of (+)-SJ733 killed 80 percent of malaria parasites within 24 hours. After 48 hours the parasite was undetectable.
Planning has begun for safety trials of the compound in healthy adults.
Laboratory evidence suggests that the compound’s speed and mode of action work together to slow and suppress development of drug-resistant parasites. Drug resistance has long undermined efforts to treat and block malaria transmission.
“Our goal is to develop an affordable, fast-acting combination therapy that cures malaria with a single dose,” said corresponding author R. Kiplin Guy, Ph.D., chair of the St. Jude Department of Chemical Biology and Therapeutics. “These results indicate that SJ733 and other compounds that act in a similar fashion are highly attractive additions to the global malaria eradication campaign, which would mean so much for the world’s children, who are central to the mission of St. Jude.”
Whole genome sequencing of the Plasmodium falciparum, the deadliest of the malaria parasites, revealed that (+)-SJ733 disrupted activity of the ATP4 protein in the parasites. The protein functions as a pump that the parasites depend on to maintain the proper sodium balance by removing excess sodium.
The sequencing effort was led by co-author Joseph DeRisi, Ph.D., a Howard Hughes Medical Institute investigator and chair of the University of California, San Francisco Department of Biochemistry and Biophysics. Investigators used the laboratory technique to determine the makeup of the DNA molecule in different strains of the malaria parasite.
Researchers showed that inhibiting ATP4 triggered a series of changes in malaria-infected red blood cells that marked them for destruction by the immune system. The infected cells changed shape and shrank in size. They also became more rigid and exhibited other alterations typical of aging red blood cells. The immune system responded using the same mechanism the body relies on to rid itself of aging red blood cells.
Another promising class of antimalarial compounds triggered the same changes in red blood cells infected with the malaria parasite, researchers reported. The drugs, called spiroindolones, also target the ATP4 protein. The drugs include NITD246, which is already in clinical trials for treatment of malaria. Those trials involve investigators at other institutions.
“The data suggest that compounds targeting ATP4 induce physical changes in the infected red blood cells that allow the immune system or erythrocyte quality control mechanisms to recognize and rapidly eliminate infected cells,” DeRisi said. “This rapid clearance response depends on the presence of both the parasite and the investigational drug. That is important because it leaves uninfected red blood cells, also known as erythrocytes, unharmed.”
Laboratory evidence also suggests that the mechanism will slow and suppress development of drug-resistant strains of the parasite, researchers said.
The Latest on: Malaria
via Google News
The Latest on: Malaria
- Christian Jessen: Embarrassing Bodies star diagnosed with malaria after Ugandan jail dramaon February 3, 2020 at 3:33 pm
Christian Jessen, 42, has revealed that he was struck down with the tropical disease malaria, when he was younger visiting Uganda on a gap year. While escorting a school trip to neighbouring Uganda, ...
- There is no malaria outbreak — ministryon February 3, 2020 at 1:55 pm
Ministry says Elgeyo Marakwet and Baringo have recorded an increase in new cases but no deaths. The Health ministry has brushed off the possibility of a malaria outbreak noting a slight increase but ...
- Supersize vs Superskinny doctor Christian Jessen once caught malaria in a Ugandan jailon February 3, 2020 at 1:26 pm
When they first begin their studies, very few medical students know what they will specialise in. But for Embarrassing Bodies presenter Dr Christian Jessen, his gap year travels made his choice easy – ...
- Fight against Malaria: A new struggle in conflict zone of Chhattisgarhon February 2, 2020 at 9:40 pm
RAJPUR: In a Red zone of Bastar in south Chhattisgarh, a different battle is being fought to tackle the vector-borne disease ‘Malaria’, which so far hasn’t received much attention. Bastar has an ...
- African Youth Health advocates petition AU on malaria controlon February 1, 2020 at 6:55 pm
Twenty-five African Youth Health advocates have petitioned the African Union (AU) to be more committed to ending the malaria epidemic and achieving Universal Health Coverage (UHC). Available statics ...
- NHRC rolls out malaria vaccination on pilot baseson February 1, 2020 at 6:55 pm
The Navrongo Health Research Centre (NHRC) in the Kassena-Nankana Municipality of the Upper East Region has vaccinated about 4,800 children against malaria, as it monitors for any adverse effects. The ...
- Scientists discover how malaria parasites import sugaron January 29, 2020 at 10:11 am
The consumption of sugar is a fundamental source of fuel in most living organisms. In the malaria parasite Plasmodium falciparum, the uptake of glucose is essential to its life cycle. Like in other ...
- Protein structure reveals how a malaria parasite imports a wide range of sugarson January 29, 2020 at 10:10 am
Unlike many sugar-transporting proteins, a transporter in one species of malaria parasite can import several types of sugar equally effectively, aiding the parasite’s survival. The structure of this ...
- Estimating hospital catchments from in-patient admission records: a spatial statistical approach applied to malariaon January 28, 2020 at 2:17 am
We set out to investigate spatial hospital accessibility for severe malarial anaemia (SMA) and cerebral malaria (CM). Malaria admissions for children between 1 month and 14 years old were identified ...
- An old plant virus inspires the design of a modern vaccine to fight against malariaon January 27, 2020 at 11:00 pm
Malaria, infecting approximately 228 million individuals in 2018, remains a meaningful threat to public health and regional stability. Large human populations live in malaria-infested regions of ...
via Bing News